Jim Strattman (@jstrattman) profile picture
Joined June 2010
Photo by Jim Strattman (@jstrattman)Photo by Jim Strattman (@jstrattman)
The politicians and regulators know. Let’s see if they do the right thing. @Siobhain_Mc met @HollensbeBrae. @HollensbeAmanda told her how surgery and DCVax saved Braelyn’s life. Listen to Brad Silver tell his story below Thank goodness he and Braelyn didn’t have to wait for approval. But think how many with glioblastoma or other solid tumors don’t even know about this promising Phase 3 non-toxic treatment? And what about the patients who do know about it, but still can’t get it?
9
1
41
1,256
I got the DCVax in 2015 @UCLAStrokeNSG by one of its creators Dr. Linda Liau after the grim diagnosis of a Glioblastoma Multiforme. I’ve thrived for over 11 & a half years. NO TUMOR RECURRENCE!!! How many times do I have to tell my story, it feels like I’m screaming into an echo chamber. F.F.S it works. @LisainNJUSA @kshaughnessy2 @DCVaxDefender @HollensbeAmanda @peter_brit @TheLastWord @LastWeekTonight
1
10
1
47
1,347
Jim Strattman retweeted
$NWBO The attached video is taken from @tiktok_us #TikTok vt.tiktok.com/ZSgQVYg9L/ My respond was removed because I said 1- #DCVAX generated better results with no toxicity. 2- the mRNA vaccine is highly toxic. Hey @tiktok_us where’s free speech in the 🇺🇸?
4
17
1
65
2,369
❤️ SUNDAY MORNING UPDATE — WE’RE GETTING SO CLOSE! ❤️ In just 12 days, Braelyn will receive her next DCVax-L treatment in London! Since my last fundraising update, more generous people have stepped forward to help us continue her treatment. We are overwhelmed by your kindness and generosity! I’ve carefully reconciled our treatment fund, GoFundMe, GiveSendGo, and private donations to share where we stand. 🎯 Estimated November 6 treatment cost: $30,844 ❤️ TOTAL FUNDS ACCOUNTED FOR: $26,308.02 🎯 ESTIMATED AMOUNT STILL NEEDED: $4,535.98 That’s more than 85% of November’s treatment covered! These figures include donations already deposited, contributions still processing through our fundraising platforms, and private gifts received but not yet deposited. Because treatment is billed in British pounds, the final dollar amount may vary slightly depending on exchange rates and fees. When I look at Braelyn today—cancer-free, attending college, and looking forward to her future—I am reminded why we continue fighting so hard for access to DCVax-L. Thank you to everyone who has donated, shared her story, prayed for her, or encouraged our family. Your generosity has helped make this journey possible. We’re getting so close to covering her November treatment! If you’re able to help us close the remaining gap, we would be incredibly grateful. Every donation, regardless of size, and every share makes a difference. Thank you for helping give Braelyn hope and a future. ❤️🙏 #DCVaxForBraelyn #DCVax #BrainCancer
11
60
8
249
37,780
Jim Strattman retweeted
$NWBO Did BMS and Merck compete to combine their checkpoint inhibitors with DCVax-L? $NWBO launched two collaboration trials at roughly the same time, one with Merck and one with BMS. The Merck trial paired DCVax-L with Keytruda in colorectal cancer; the BMS trial paired DCVax-L with Opdivo in rGBM. The BMS trial was later withdrawn and replaced by the current combination trial. The SPORE project, which adds a CSF1R inhibitor to the DCVax-L/checkpoint inhibitor combination, originally had BMS as its sponsor. When the SPORE was renewed in 2022, Merck took over as sponsor and BMS was out. My suspicion is that by 2022 it had become clear that tumor-associated macrophages, which a CSF1R inhibitor can deplete, were the main barrier to further improving efficacy. IMO, Merck was probably confident it had everything under control, with the Moderna collaboration serving as cover. Note that BMS, which knows DCVax-L well, has shown no interest in mRNA, despite running over 20 collaboration trials with BNTX. But the MOU caught Merck completely off guard, which may explain why it rushed out mediocre data on its mRNA cancer vaccine. It strikes me that the only way Merck can build a real stronghold in immunotherapy is to write LP an upfront check so big she can't say no. And LP fully deserves one. Merck was able to make many of its acquisitions at bargain prices partly because those companies didn't realize what their products could do in combination with DCVax-L. NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L and Pembrolizumab (Keytruda®) for Colorectal Cancer nwbio.com/nw-bio-announces-p… Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma clinicaltrials.gov/study/NCT…
Here is the absolute bottom line for $MRNA 📊 2-Year RFS Rates: • Keytruda alone: 70.0% • Vaccine + Keytruda: 82.2% • Absolute Risk Reduction: Just 12.2% SO FOR AN EXTRA $100,000 YOU CAN GET A 12% LOWER RISK OF DEATH. THAT’S IT WHO THE FUCK IS GOING TO PAY FOR THAT? WHICH INSURANCE COMPANY IS GOING TO UNDERWRITE THAT? NOT TO MENTION YOU’RE TAKING AN EXPERIMENTAL mRNA VACCINE THAT IS 90 TIMES HIGHER DOSE THAN THE COVID VACCINE. $MRK $LLY $JNJ $LLY $QQQ $SPY
1
7
35
1,088
Jim Strattman retweeted
$NWBO In the SWOG S1801 trial, Keytruda was dosed at 200 mg every three weeks, while the personalized mRNA vaccine trial used 400 mg every six weeks. Why choose the 400 mg schedule? My suspicion is that they wanted a higher peak exposure to seize the transient window before T-cell exhaustion kicks in. The personalized mRNA vaccine results are rather mediocre, and neoadjuvant therapy has shown much better results. Yet the media keeps hyping the vaccine. Let's see how long that lasts. Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma nejm.org/doi/full/10.1056/NE… A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma clinicaltrials.gov/study/NCT… Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma nejm.org/doi/abs/10.1056/NEJ…
$MRNA with the single most hilarious possible outcome in this study. EFS HR 0.58. Down the the hundredth, EXACTLY what *NEO*-adjuvant treatment with pembro yielded against adjuvant pembro (the nerfed comparator $MRNA studied against) in SWOG S1801. What does this mean in English? $MRNA’s drug is showing the exact same benefit versus adjuvant pembrolizumab as NEOadjuvant pembrolizumab did. Even more simply? If you just give patients a few doses of the pembrolizumab BEFORE you cut their cancer out, you do what $MRNA does for you, except with just the free tumor that’s already inside your body. No need to pay for this $400K drug. And this makes rational sense, right? The whole point of $MRNA’s vaccine is to produce stuff that looks like the tumor. You know what looks A LOT like the tumor does? THE FREAKING TUMOR!!!!!! Absolutely poetic that $MRNA produced the EXACT HR benefit as neoadjuvant pembro did. Truly, the most hilarious possible outcome. Now can we move on from this bullshit? $MRK and $MRNA should feel free to study their vaccine against the REAL standard of care now - NEOadjuvant immunotherapy. From my perspective, this has been total fugaze, and an amateurish pump and dump worthy of much lesser enterprises.
3
21
859
🇺🇸❤️ WE MET PRESIDENT TRUMP TONIGHT! ❤️🇺🇸 What an extraordinary evening for our family! Tonight, Braelyn, Ben, and I had the incredible opportunity to meet President Trump at the rally in Pendleton, South Carolina! We had only about 20–30 seconds with him, and I knew I needed to make every second count. I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story. I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America! Yet we must travel all the way to England for her ongoing treatments because we cannot access it here in the United States. Then something pretty cool happened! President Trump turned to one of his staffers and instructed them to get me in touch with Dr. Oz! I also expressed my hope that we could connect with Secretary Kennedy. As our brief time together came to an end, I made one final appeal: “Please help bring this American-made treatment back home to America.” President Trump was incredibly gracious to our family and very kind to Braelyn. We are so grateful for the opportunity to speak with him! Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments. Now we are praying that the connection with Dr. Oz comes through! Three years ago, Braelyn was given just months to live. Today, she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE! Tonight, we had the opportunity to bring her story directly to the President of the United States. ❤️ My prayer is that this opens the door to a much bigger conversation—one that could change the future for countless American cancer patients. 📸 We were not permitted to bring our phones into the private meeting with President Trump, so we couldn’t take our own pictures with him. His staff took an official photograph of us together, which we’re told will be emailed to us. I can’t wait to share it! In the meantime, here are some pictures from our unforgettable evening. Thank you to EVERYONE who helped make tonight possible and to all of you who continue to share Braelyn’s story. You helped us get this far, and we’re not stopping now! ❤️🙏 @realDonaldTrump @DrOzCMS @WhiteHouse #DCVaxForBraelyn #DCVax
91
199
36
730
56,443
Jim Strattman retweeted
Again $MMTLP stayed on OTC for about 14 months and one billion counterfeit shares were created! $NWBO has been on OTC for about ten years. What should be the number for the company? I suspect LP should know the number!
Replying to @nbhydrocarbons
The segment will air at 2 pm EST. Mr. Payne is a dedicated campaigner for truth and transparency in our capital markets and a true advocate for shareholder rights and protections. We are truly pleased for this opportunity to share our story with his viewers. Be sure to tune in!
11
35
1,220
❤️ IT’S OFFICIAL! WE’RE MEETING PRESIDENT TRUMP TOMORROW! 🇺🇸 Braelyn and I have been invited to attend tomorrow’s rally for Darline Graham in Clemson! We’ll be seated in the VIP section AND have the opportunity to meet President Trump in the “click line”! Ben is cutting his work trip short, and we’re hoping he’ll make it home in time to join us! We’ll have only seconds with the President, but I intend to make every one of them count. I’ll also be bringing information for him and his staff about Braelyn, DCVax-L, and the barriers American patients face trying to access promising treatments developed right here in the United States. This is an extraordinary opportunity, but we’re hoping it can become something even bigger. PLEASE HELP US GET THE ATTENTION OF THE WHITE HOUSE PRESS TEAM! 🙏 We would love the opportunity for a longer conversation with President Trump or his administration about how we can make these treatments accessible to American patients. Please SHARE, REPOST, and TAG anyone who might help get Braelyn’s story in front of the right people! Three years ago, Braelyn was given just months to live. Today she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE! Her story deserves to be heard. And so do the stories of countless other patients fighting for access to promising treatments. @realDonaldTrump @DrOzCMS @WhiteHouse #DCVaxForBraelyn #DCVax #PresidentTrump
140
266
68
774
82,241
Jim Strattman retweeted
$NWBO The combination trial was designed to be double-blind. In November 2020, after receiving the second DC vaccination, patient #5 developed such an intense anti-tumor immune response that surgery was needed to remove inflamed tissue caused by T-cell infiltration. Dr. Liau also had to prescribe tocilizumab, an IL-6 blocker approved for rheumatoid arthritis, to calm the response. After a reaction that strong, the investigators knew the patient was in Arm A and the trial was not blind to them. I suspect that if an immune response this strong had shown up in the Merck–Moderna trials, both companies would have made sure the whole world knew about it. Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma clinicaltrials.gov/study/NCT… clinicaltrials.gov/search?te…
3
14
1
46
2,176
$NWBO longs please take a read of this. I know folk are fed up & frustrated beyond beleif, but I strongly beleive the public rage baiting of UK Civil servants; MPs; Professours like Prof A. Chalmers & others involved w/ UK GBM Research has to stop now! investorshub.advfn.com/board…
12
9
1
89
2,919
The research is there! DCvax by $NWBO has completed phase III trials with remarkable results. There are a number of GBM longterm survivors. GBM patients don’t have time for just more research. Bring this proven treatment to them now while advancing the research.
A message to the Prime Minister: please listen to Archie Goodburn when you see him and increase funding into brain cancer research. @braintumourrsch @andyburnham
5
71
9
202
5,254
Jim Strattman retweeted
Replying to @JoshTay02205534
$NWBO I’ve never seen the company this aggressive and confident before. Dr. Bosch essentially argued that three competing approaches (CAR-T, neopeptide vaccines, and mRNA cancer vaccines) are all inferior to DCVax-L.
14
53
719
Jim Strattman retweeted
Replying to @EscaleraCapital
Especially the one in charge of SPIMACO who called $NWBO a strategic partner and a global innovator. And SPIMACO saw the important potential of DCVax technologies (plural).
3
19
400
Jim Strattman retweeted
Replying to @jaygreco194737
My hunch is that the number of counterfeit shares is far larger than 2 billion. Once $NWBO was pushed to the OTC, they all assumed it would go bankrupt and they could do whatever they liked. As Logan pointed out in the interview, once a company is gone, everything disappears without a trace. MMTLP sat on the OTC for about 15 months and reportedly ended up with a billion counterfeit shares. $NWBO has been on the OTC for nearly 10 years. The number could be staggering, IMO. Now we know why so many people have been attacking this company around the clock for years. And here comes another beauty of the MOU: it could turn those counterfeit shares into real ones.
2
12
1
43
1,290
Jim Strattman retweeted
It is Braelyn. I know this.
I choose to believe that this "kid" is Braelyn!
23
74
18
319
39,354
I don’t even know how to adequately thank you for this. ❤️ What started as a desperate mom coming to X looking for answers has become a community of people helping us find treatment, fund it, share Braelyn’s story and advocate for patients who come after her. @peterjkostis, using a platform of this size to help amplify her story is an extraordinary gift. Thank you for seeing that this is about so much more than one family. If enough people keep asking why patients must cross an ocean to access this treatment, maybe we really can help change what comes next. #DCVaxForBraelyn
Social media can be a very negative place but it can also do much good. It's time for "power to the people" to create a viral story about Braelyn ... NWBO... and DCVax-L. Maybe with enough social media noise we can get this life saving vaccine across the finish line!!
2
28
140
2,360